Skip to content Skip to footer
Subscribe Now
Viewpoint_Peony_Yu_2020
VIEWPOINTS

PharmaShots Interview: FibroGen’s Peony Yu Shares Insight on Roxadustat

In a recent interview with PharmaShots, Peony Yu, Chief Medical Officer of FibroGen shared her insights and highlights on data of Roxadustat Shots: FibroGen presented new efficacy and safety analyses from the roxadustat global P-III program at ASN Kidney Week 2020 Reimagined. FibroGen and its partners, AstraZeneca and Astellas, presented 42 abstracts, including 2 late-breaker poster presentations,…
December 7, 2020

Read more

Viewpoint_Julie_Foster_2020
VIEWPOINTS

PharmaShots Interview: Medtronic’s Julie Foster Shares Insight on InPen Integrated with Guardian Connect CGM

In a recent interview with PharmaShots, Julie Foster, Vice President, Global Customer Experience of the Diabetes business at Medtronic, shares information about recent and upcoming announcements for the company. Shots: The integration of real-time CGM data into the smart insulin pen app follows the acquisition of Companion Medical's InPen to the Medtronic portfolio, as of Sept'2020 The…
December 2, 2020

Read more

Viewpoint_Dr. David_Spetzler_2020
VIEWPOINTS

PharmaShots Interview: Caris Life Sciences’ Dr. Spetzler Shares Insight on AI-Powered Clinico-Genomic Data Platform

In a recent interview with PharmaShots, Dr. Spetzler, President and Chief Scientific Officer of Caris Life Sciences shared his insights and highlights on the launch of CODEai. Shots: CODEai is a real-world clinico-genomic data platform that integrates Caris Life Sciences extensive catalog of molecular data with cancer treatment information and clinical outcomes data for ~215,000…
December 1, 2020

Read more

Viewpoint_Aidan_Foley_2020
VIEWPOINTS

PharmaShots Interview: True Digital Surgery’s Aidan Foley Shares Insight on the Aesculap Aeos Robotic Digital Microscope

In a recent interview with PharmaShots, Aidan Foley, Chairman and Chief Executive Officer of True Digital Surgery shared his insights and highlights on data of the Aesculap Aeos Robotic Digital Microscope. Shots: The robotic digital microscope enables surgeons to execute precision movements in neurosurgery, spine, and ear, nose, and throat operations, through a multi-axis robotic arm. The platform utilizes…
November 26, 2020

Read more

Viewpoint_Dr. Eiry_Roberts_2020
VIEWPOINTS

PharmaShots Interview: Neurocrine’s Dr. Eiry Roberts Shares Insight on Ongentys (opicapone)

In a recent interview with PharmaShots, Dr. Eiry Roberts, Chief Medical Officer of Neurocrine Biosciences shares her insights and highlights on data of Ongentys. Shots: In a post-hoc, sub-group analysis of the P-III BIPARK-1 study demonstrated greater reductions in overnight "off" time and time to morning "on" time compared to entacapone in patients with PD…
November 16, 2020

Read more

Viewpoint_Douglas_Fambrough_2020
VIEWPOINTS

PharmaShots Interview: Dicerna’s Doug Fambrough Shares Insight on Nedosiran Data Presented at ASN Week 2020

In a recent interview with PharmaShots, Doug Fambrough, Ph.D., President and CEO of Dicerna shares his insights and highlights on data of Nedosiran presented at ASN Week 2020. Shots: All participants regardless of PH subtype, achieved normal or near-normal Uox excretion @day180, 92% participants (100% & 67% with PH1 & PH2) achieved normal Uox excretion…
November 9, 2020

Read more

Insight+_Senior Editor
INSIGHTS+

Insights+ Key Biosimilars Events of October 2020

Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency During the month of October, Henlius signed two agreements for its biosimilar products and presented results of HLX03 (biosimilar, adalimumab) whereas Samsung Bioepis and Biogen announced EMA filing acceptance of SB11 (biosimilar, ranibizumab) Our team at PharmaShots…
November 5, 2020

Read more

Load more